We are evaluating the safety and tolerability of an experimental new drug (AK120) being developed to help individuals who have moderate to severe eczema. This study drug will be administered as an injection.
For this trial we need the help of males and females who are not pregnant or are not able to bear children, aged from 18-65 (inclusive) who are in good health with moderate to severe eczema. They must have moderate to severe eczema for at least one year and must not have a history of alcohol or drug abuse.
If you meet the criteria for this study and would like more information, register below or call 1800 727 874.